Skip to content

Effect Of Orthoboon in the Management of Periodontitis : A Randomized Clinical Study

Evaluation of Role of Host Modulating Agent Orthoboon in the Management of Periodontitis : A Randomized Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053345
Enrollment
26
Registered
2023-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Scaling and root planing with host modulatory agent orthoboon: Orthoboon, is an anti-inflammatory drug, which constitutes of a combination of Glucosamine Sulfate, Vitamin C, and collage

Sponsors

Dr Rashmi Jha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Stage II/ III, Grade A Periodontitis. Systemically healthy patients. No surgical periodontal therapy in last 6 months

Exclusion criteria

Exclusion criteria: Not willing for participation in the study. Pregnant and lactating women. Patients who are on diuretics, steroids, anti-coagulants, oral contraceptives. Patients having diabetes mellitus, asthama, peptic ulcer, blood dyscrasias, nutritional deficiencies, liver disease, infected with immunodeficiency virus, acquired immunodeficiency syndrome. Patients who are addicted to tobacco, alcohol, and cigarette smoking

Design outcomes

Primary

MeasureTime frame
C Reactive ProteinTimepoint: Baseline before scaling and root planing 45 Days after scaling and root planing

Secondary

MeasureTime frame
bleeding index plaque indexTimepoint: baseline before scaling and root planing 45 Days after scaling and root planing

Countries

India

Contacts

Public ContactDr Rashmi Jha

KM SHAH DENTAL COLLEGE

drneerajd.kmsdch@sumandeepvidyapeethdu.edu.in7600918500

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026